mesoblast

Stem cell pioneer lures big pharma

by Tony BoydJust when Australia’s beaten-down biotech sector was in need of a boost, Silviu Itescu at stem cell pioneer Mesoblast sends positive signals by selling $58.5 million in stock to US pharmaceutical giant, Celgene Corporation.This is a hugely important transaction for Mesoblast and the Australian biotech sector. It shows big pharma is not content to sit back and rely on […]